Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma

SIMPLE SUMMARY: Multiple Myeloma (MM) is the most common cancer of the bone marrow and remains incurable despite advances in novel therapy. The disease course is typically characterized by an initial response pattern to treatment followed by eventual relapse and treatment refractoriness. Patients wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Yarlagadda, Lakshmi, Gundarlapalli, Sravani, Parikh, Richa, Landes, Reid D., Kottarathara, Mathew, Ogunsesan, Yetunde, Hoque, Shadiqul, Mitma, Angel A., Bailey, Clyde, Hill, Kerri M., Thanendrarajan, Sharmilan, Graziutti, Monica, Mohan, Meera, Zangari, Maurizio, van Rhee, Frits, Tricot, Guido, Schinke, Carolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392190/
https://www.ncbi.nlm.nih.gov/pubmed/34439174
http://dx.doi.org/10.3390/cancers13164019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392190/
https://www.ncbi.nlm.nih.gov/pubmed/34439174
http://dx.doi.org/10.3390/cancers13164019

Ejemplares similares